# Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across risk strata: Divergence of conclusions with risk difference and difference in restricted mean survival time
Carolien C.H.M. Maas[1, 2, 3], David M. Kent[3], Avinash G. Dinmohamed[1, 2], David van Klaveren[1, 3]
[1]Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands
[2]Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands
[3]Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, USA

### Corresponding author
Carolien C.H.M. Maas, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, Netherlands, c.h.m.maas@erasmusmc.nl
